Xbiotech Inc
(XBIT)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
by (Cboe BZX)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
[[ item.lastPriceExt ]]
[[ item.priceChangeExt ]]
([[ item.percentChangeExt ]])
[[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 09-2015 | 06-2015 | 03-2015 | 12-2014 | 09-2014 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 105,680 | 117,382 | 52,236 | 57,329 | 0 |
| Other current assets | 0 | 0 | 1,036 | 324 | 0 |
| TOTAL | $107,587 | $120,353 | $53,765 | $58,064 | $0 |
| Non-Current Assets | |||||
| PPE Net | 4,854 | 3,813 | 4,923 | 3,227 | N/A |
| Other Non-Current Assets | 6,606 | 2,681 | 0 | 886 | 0 |
| TOTAL | $11,460 | $6,494 | $4,923 | $4,113 | $N/A |
| Total Assets | $119,047 | $126,847 | $58,688 | $62,177 | $0 |
| Liabilities | |||||
| Current Liabilities | |||||
| Accounts payable and accrued liabilities | 3,964 | 2,285 | 2,915 | 1,629 | 0 |
| Accrued Expenses | 994 | 580 | 911 | 1,518 | 0 |
| TOTAL | $4,958 | $2,865 | $3,826 | $3,147 | $0 |
| Non-Current Liabilities | |||||
| Other Non-Current Liabilities | 12 | 7 | 2 | 0 | 0 |
| TOTAL | $12 | $7 | $2 | $N/A | $N/A |
| Total Liabilities | $4,970 | $2,872 | $3,828 | $3,147 | $0 |
| Shareholders' Equity | |||||
| Shares Outstanding, K | 32,184 | 32,053 | 31,985 | N/A | N/A |
| Common Shares | 232,850 | 231,935 | 156,393 | 152,351 | 0 |
| Retained earnings | -118,762 | -108,026 | -101,282 | -93,168 | 0 |
| Other shareholders' equity | -11 | 66 | -251 | -153 | 0 |
| TOTAL | $114,077 | $123,975 | $54,860 | $59,030 | $0 |
| Total Liabilities And Equity | $119,047 | $126,847 | $58,688 | $62,177 | $0 |